Meeting
2020 ASCO Virtual Scientific Program
First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes.
Presenter
Yuanbin Chen, MD, PhD
Cancer & Hematology Centers of Western Michigan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Small Cell Lung Cancer
Clinical Trial Registration Number
NCT03043872
Citation
J Clin Oncol 38: 2020 (suppl; abstr 9068)
DOI
10.1200/JCO.2020.38.15_suppl.9068
Abstract #
9068
Poster Bd #
261
Abstract Disclosures
Similar Videos & Slides
Videos & Slides
2024 ASCO Annual Meeting
An open label, single arm phase II, multicenter trial of durvalumab and BVAC-C, in patients with HPV 16- or 18-positive cervical cancer and failure of first-line platinum-based chemotherapy (DURBAC).
Speaker: Chel Hun Choi, MD, PhD
Videos & Slides
2023 ASCO Annual Meeting
Results of the multicenter phase II FRAIL-IMMUNE trial evaluating the efficacy and safety of durvalumab combined with weekly paclitaxel carboplatin in first-line in patients (pts) with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) not eligible for cisplatin-based therapies.
Speaker: Jerome Fayette, MD, PhD
Videos & Slides
2023 ASCO Annual Meeting
Randomized phase 3 study of first-line AZD3759 (zorifertinib) versus gefitinib or erlotinib in EGFR-mutant (EGFRm+) non–small-cell lung cancer (NSCLC) with central nervous system (CNS) metastasis.
Speaker: Yi-Long Wu, FACS
Videos & Slides
2023 ASCO Genitourinary Cancers Symposium
Outcomes of patients with brain metastases from renal cell carcinoma treated with first-line therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
Speaker: Kosuke Takemura, MD, PhD, MPH